|
ALG6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44089209850063E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.36477504245158E-14 |
| Normal-vs-Stage2 |
4.70401495533679E-12 |
| Normal-vs-Stage3 |
2.1316282072803E-14 |
| Normal-vs-Stage4 |
2.21178630965824E-12 |
| Stage1-vs-Stage2 |
2.422600E-01 |
| Stage1-vs-Stage3 |
2.040800E-01 |
| Stage1-vs-Stage4 |
9.888300E-02 |
| Stage2-vs-Stage3 |
8.363000E-01 |
| Stage2-vs-Stage4 |
7.156000E-01 |
| Stage3-vs-Stage4 |
5.315000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.440500E-03 |
| Normal-vs-Asian |
1.07789999148622E-10 |
| Caucasian-vs-AfricanAmerican |
2.031800E-01 |
| Caucasian-vs-Asian |
6.274800E-01 |
| AfricanAmerican-vs-Asian |
3.471200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.55191440096314E-15 |
| Normal-vs-Female |
1.62558855265615E-12 |
| Male-vs-Female |
4.662000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70130576293559E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.57920343468732E-11 |
| Normal-vs-Age(81-100Yrs) |
2.842700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.542400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.888200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.449800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.857590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.201600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.140600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.448140E-02 |
| Classical-VS-Follicular |
3.653800E-01 |
| Classical-VS-Other |
1.234980E-01 |
| Classical-VS-Normal |
1.69397829097306E-12 |
| Tall-VS-Follicular |
8.870500E-02 |
| Tall-VS-Other |
7.523200E-01 |
| Tall-VS-Normal |
6.14119866071405E-12 |
| Follicular-VS-Other |
3.249200E-01 |
| Follicular-VS-Normal |
4.30209978752316E-10 |
| Other-VS-Normal |
1.96292999999903E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31006316905768E-14 |
| Normal-vs-N1 |
3.33066907387547E-16 |
| N0-vs-N1 |
3.607800E-02 |
|
|
